Events and Networking

Expand Your Network at One of Biocom’s 150+ Annual Events

Why the Current CRO Model May Be Failing

When

Wed Jun 14 15:00:00 GMT 2017 - Wed Jun 14 17:00:00 GMT 2017

Where

10996 Torreyana Road Suite 200
San Diego, California 92121

Register

Why the Current CRO Model May Be Failing Developers, Investors and Patients
The first in a series of “Concept to Commercialization” presentations, this lecture will examine why the current CRO model may be failing developers, investors and patients.  Does a new model CRO need introduction to the industry?  Yes, according to pharmaceutical leader James Nolan, one that includes these four, key elements and available at the earliest stages of development:
 

  • A reimbursement strategy
  • Regulatory experts
  • Pre-IND evaluation capabilities
  • Patient access experts.
 
These added capabilities will allow CROs to separate themselves in a highly competitive industry. Mr. Nolan will also detail key issues complicating the concept to commercialization path for drug developers.

Speaker: 
James Nolan, CEO, InClinica

Price of Admission

Members

Today's Price: 0.0

Important Dates

Amount

Registration Before

Registration Before

Registration Before

Refund after Mon Jun 12 00:00:00 GMT 2017

0.0

Refund after

Refund after

Industry Non-Members

Today's Price: 25.0

Important Dates

Amount

Registration Before

Registration Before

Registration Before

Refund after Mon Jun 12 00:00:00 GMT 2017

25.0

Refund after

Refund after

 

Register